Avidity Partners Management LP Glaukos Corp Transaction History

Avidity Partners Management LP

  • $194 Million
  • Q3 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$96.6 - $161.22 $3.48 Million - $5.8 Million
-36,000 Reduced 21.18%
134,000 $13.2 Million
Q4 2024

Feb 14, 2025
SELL
$126.42 - $152.67 $22.1 Million - $26.7 Million
-174,900 Reduced 50.71%
170,000 $25.5 Million
Q3 2024

Nov 14, 2024
BUY
$113.62 - $135.39 $13.7 Million - $16.4 Million
120,900 Added 53.97%
344,900 $44.9 Million
Q1 2024

May 15, 2024
BUY
$76.4 - $96.33 $17.1 Million - $21.6 Million
224,000 New
224,000 $21.1 Million

Others Institutions Holding GKOS

# of Institutions
351
Shares Held
55.3M
Call Options Held
163K
Put Options Held
458K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $4.29B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email